Understanding GLP-1 Titration: Why Your Dose Increases Over Time
GLP-1 medications start at a low dose and increase gradually. Here's why titration matters, what the schedules look like, and what to expect at each step.
Understanding GLP-1 Titration: Why Your Dose Increases Over Time
If you're starting a GLP-1 medication, your first dose will almost certainly be lower than your eventual target dose. This gradual increase—called titration—is standard practice for semaglutide and tirzepatide. Here's why it happens and what to expect.
Why Doctors "Start Low and Go Slow"
The main reason for titration is gastrointestinal tolerability. GLP-1 medications slow stomach emptying and affect appetite signals, and starting at a full dose often causes significant nausea, vomiting, or diarrhea. By beginning with a small dose and increasing it over several weeks, your body adapts and side effects are usually milder.
Titration also helps your clinician see how you respond at each level. If side effects become difficult at a certain dose, they can hold that dose longer or adjust the plan.
Semaglutide (Wegovy) Titration Schedule
Wegovy is titrated over roughly 16–20 weeks:
| Weeks | Dose |
|---|---|
| 1–4 | 0.25 mg once weekly |
| 5–8 | 0.5 mg once weekly |
| 9–12 | 1.0 mg once weekly |
| 13–16 | 1.7 mg once weekly |
| 17+ | 2.4 mg once weekly (maintenance) |
Not everyone reaches 2.4 mg. Some people stay at an intermediate dose if it's working well and higher doses cause side effects.
Tirzepatide (Zepbound) Titration Schedule
Zepbound is titrated over 20 weeks or more:
| Weeks | Dose |
|---|---|
| 1–4 | 2.5 mg once weekly |
| 5–8 | 5 mg once weekly |
| 9–12 | 7.5 mg once weekly |
| 13–16 | 10 mg once weekly |
| 17–20 | 12.5 mg once weekly |
| 21+ | 15 mg once weekly (maintenance) |
As with semaglutide, the maintenance dose is individualized. Many people reach meaningful results at 5 mg, 10 mg, or another intermediate dose.
What to Expect at Each Step
The first few weeks are about tolerability, not maximum effect. You may notice reduced appetite, but the full effect builds as the dose increases.
Each titration step can briefly reintroduce mild side effects—nausea, fatigue, or changes in digestion—as your body adjusts to the new concentration. These typically ease within a week or two.
At maintenance dose, appetite suppression and metabolic effects are at their strongest for your prescribed plan.
What If a Step Is Too Much?
If side effects are difficult at a new dose, your clinician may:
- Hold the current dose longer before increasing again
- Return to the previous dose
- Adjust timing, hydration, or meal patterns
- In rare cases, switch to a different medication
Never increase your dose on your own. Titration schedules are designed around safety data and clinical experience.
Compounded GLP-1s and Titration
Compounded semaglutide and tirzepatide generally follow the same titration logic, but concentrations and dosing units differ by pharmacy. Always follow the specific instructions provided with your compounded medication and confirm the schedule with your prescriber.
The Bottom Line
Titration is a normal, intentional part of starting a GLP-1. Starting low and increasing gradually reduces side effects and helps your clinician find the right maintenance dose for you. If a step feels difficult, talk to your provider—there's almost always an adjustment that can help.
This article is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional about medication decisions.
Medical Disclaimer
This content is for educational purposes only and is not medical advice. GLP-1 Primer does not recommend or endorse any specific medication, provider, or treatment. Always consult a licensed healthcare professional before making decisions about your health.
